2 results
Approved WMOCompleted
The main objective of Study M15-722 is to characterize the efficacy, safety, and tolerability of ravagalimab (ABBV-323) as induction treatment in subjects with moderately to severely active UC.
Approved WMOCompleted
The objective of this study is to assess the feasibility of HCP measurements in CRT patients during different pacing settings. We will evaluate the accuracy of LV volumetric measurements in patients with an implanted CRT. For this evaluation, LV…